ALISON GRACOM: Open Payments
NPI 1245496843 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82,081 in 129 payments from 13 companies in 2025. Trend: 2023 $94,878 · 2024 $126,193 · 2025 $82,081
Speaker / faculty: $56,480Travel & lodging: $18,526Food & beverage: $3,076Honoraria: $2,100Consulting: $1,857Education: $43
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 91 | $78,184 |
| Xeris Pharmaceuticals, Inc. | 17 | $3,284 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $224 |
| ABBVIE INC. | 5 | $94 |
| Mannkind Corporation | 3 | $77 |
| Surgenex LLC | 3 | $68 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| REVANCE THERAPEUTICS, INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: Korlym, RECORLEV, ISTURISA, AFREZZA, SurGraft, JARDIANCE, LO LOESTRIN FE, Symbravo.
Industry payments across CA — which companies pay providers there.
